HighVista Strategies’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-2,743
Closed -$763K 139
2023
Q1
$763K Hold
2,743
0.62% 53
2022
Q4
$760K Buy
+2,743
New +$775K 0.45% 65
2020
Q1
Sell
-11,590
Closed -$3.44M 76
2019
Q4
$3.44M Hold
11,590
2.61% 9
2019
Q3
$2.7M Hold
11,590
1.84% 16
2019
Q2
$2.71M Sell
11,590
-18,319
-61% -$4.23M 1.39% 17
2019
Q1
$7.07M Buy
29,909
+1,200
+4% +$378K 5.77% 1
2018
Q4
$8.64M Sell
28,709
-4,600
-14% -$1.47M 7.47% 2
2018
Q3
$11.8M Buy
33,309
+200
+0.6% +$68.9K 5.49% 5
2018
Q2
$9.61M Sell
33,109
-100
-0.3% -$28.1K 4.34% 6
2018
Q1
$9.09M Buy
33,209
+100
+0.3% +$31K 3.88% 7
2017
Q4
$10.5M Sell
33,109
-300
-0.9% -$96.2K 2.94% 8
2017
Q3
$10.5M Sell
33,409
-600
-2% -$178K 2.38% 11
2017
Q2
$9.23M Sell
34,009
-500
-1% -$132K 2.1% 14
2017
Q1
$9.44M Sell
34,509
-17,600
-34% -$4.98M 2.11% 13
2016
Q4
$14.8M Buy
52,109
+3,300
+7% +$978K 2.9% 10
2016
Q3
$15.3M Buy
48,809
+2,609
+6% +$773K 2.83% 7
2016
Q2
$11.2M Buy
+46,200
New +$12.2M 2.14% 12

Other funds holding BIIB

HighVista Strategies's BIIB Position: Q2 2023 in Review

HighVista Strategies sold out of Biogen (BIIB) in Q2 2023, closing a stake of 2,743 shares — an estimated $763K sold.

HighVista Strategies first reported a position in BIIB in Q2 2016 and held it in 17 quarters. The position peaked at $15.3M in Q3 2016. 1,008 funds tracked by Wall St. Rank hold BIIB as of Q2 2023.

  • HighVista Strategies reported no remaining Biogen position as of Q2 2023 after selling out during the quarter.
  • HighVista Strategies sold 2,743 Biogen shares in Q2 2023, an estimated $763K.
  • HighVista Strategies first reported a position in Biogen in Q2 2016 and held it in 17 quarters.
  • HighVista Strategies's Biogen position peaked at $15.3M in Q3 2016.
  • 1,008 funds tracked by Wall St. Rank held Biogen as of Q2 2023.

Based on HighVista Strategies's 13F filing for Q2 2023, filed 14 Aug 2023.